SOURCE: MediSwipe, Inc.

MediSwipe, Inc. Logo

November 14, 2013 09:40 ET

MediSwipe Inc. Announces Approval of Michigan Bill Paving Way to Allow Michigan Medical Marijuana Sales via Pharmacies and Approved Grow Operations

LOS ANGELES, CA--(Marketwired - November 14, 2013) - MediSwipe Inc. ( (OTCQB: MWIP), the leader in Compassionate Care Technology Solutions for the medicinal marijuana industry, today announced that the Michigan Senate passed a bill yesterday that would allow pharmacies and approved grow operations to sell medical marijuana. The Bill passing by a 22-16 margin, now moves to the House where further debate is expected.

The measure, now known as Senate Bill 660, seeks to address the major problem with Michigan's medical marijuana program. Presently, the initial law doesn't outline approved methods for patients to obtain medicinal marijuana, beyond caregivers. Under the new proposed Bill, pharmacies could dispense marijuana to patients via an "enhanced medical cannabis card" under a separate registry than the one that currently exists. These pharmacies, as well as cultivation operations supplying them, would have to obtain licenses via the Michigan Board of Pharmacy. They would also be subject to regulations and inspections. Michigan patients would also have to agree not to grow for themselves.

The measure could eventually box out current and former dispensary owners, especially if the state doesn't pass separate regulations officially allowing traditional dispensaries or regulated cannabis centers to operate and could potentially open the door for large pharmaceutical companies.

MediSwipe believes that the bill would bring some stability to the business climate and create new opportunities for large-scale growing operations, packaging companies and labs (as all cannabis would have to be tested). Although, even if the bill passes in both houses, it would not go into effect until (and unless) the federal government reclassifies marijuana as a Schedule II drug. The Drug Enforcement Agency has the ability to reschedule marijuana, but it has rejected the notion in the past.

The new proposal could greatly improve the current system, where a patchwork of unregulated dispensaries exist in a legal gray area. Many centers have been forced to close over the past two years due to a recent crackdown and several unfavorable court rulings in Michigan. Those still in business face the daily threat of closure. As for the fact that the bill depends on federal rescheduling of marijuana, the thinking is that the measure could help persuade the US government to move in that direction.

"There is an obvious need for change with present legislation in Michigan, and we believe Bill 660 although a long road ahead, is a step in the right direction. Ironically, Michigan has more patients registered within the state, with over 130,000 exceeding Colorado, the most progressive state with clear medicinal laws and licensing. This is a first and important step in the right direction, clarifying how patients may legally obtain their medicine. MediSwipe is in the perfect position to capitalize on this opportunity being based in Michigan, and being the only Company within the sector focused on patient security, databasing, and doctor's compliant software applications specifically for this industry. We have always believed meaningful revenues for this sector will be based on big data and compliance and will continue follow our strategic plan for growth in this arena," stated B. Michael Friedman.

MediSwipe Inc.
MediSwipe Inc. ( provides innovative patient solutions and is the leader in Compassionate Care Technology for the medicinal marijuana industry. MediSwipe provides terminal-based service packages and integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, Check Guarantee and Accounts.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.

Contact Information